ZOTA HEALTH CARE
|
ZOTA HEALTH CARE Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -5.55 | -2.29 | 3.54 | -0.09 | 1.12 |
| CEPS(Rs) | 2.22 | 2.46 | 5.00 | 1.21 | 1.97 |
| DPS(Rs) | 1.00 | 1.00 | 1.50 | 1.00 | 1.00 |
| Book NAV/Share(Rs) | 34.81 | 31.94 | 35.62 | 26.99 | 28.02 |
| Tax Rate(%) | 11.23 | -23.06 | 28.37 | 42.83 | 29.00 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 4.19 | 4.76 | 11.00 | 0.54 | 4.74 |
| EBIT Margin(%) | -6.30 | -1.52 | 9.72 | -0.24 | 4.13 |
| Pre Tax Margin(%) | -8.96 | -3.35 | 9.48 | -0.34 | 4.06 |
| PAT Margin (%) | -7.95 | -4.12 | 6.79 | -0.20 | 2.88 |
| Cash Profit Margin (%) | 3.18 | 4.42 | 9.59 | 2.77 | 5.09 |
| Performance Ratios | |||||
| ROA(%) | -7.53 | -3.90 | 7.94 | -0.24 | 3.08 |
| ROE(%) | -16.85 | -6.79 | 11.43 | -0.31 | 3.98 |
| ROCE(%) | -12.30 | -2.50 | 16.36 | -0.38 | 5.71 |
| Asset Turnover(x) | 0.95 | 0.95 | 1.17 | 1.23 | 1.07 |
| Sales/Fixed Asset(x) | 1.56 | 2.10 | 3.37 | 3.68 | 3.93 |
| Working Capital/Sales(x) | 4.76 | 3.21 | 3.20 | 2.48 | 2.36 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.64 | 0.48 | 0.30 | 0.27 | 0.25 |
| Receivable days | 55.69 | 83.71 | 90.61 | 98.96 | 98.30 |
| Inventory Days | 96.62 | 92.24 | 79.46 | 91.46 | 111.01 |
| Payable days | 113.36 | 98.97 | 72.26 | 76.17 | 85.77 |
| Valuation Parameters | |||||
| PER(x) | - | - | 84.06 | - | 116.69 |
| PCE(x) | 213.77 | 114.63 | 59.53 | 114.93 | 66.11 |
| Price/Book(x) | 13.63 | 8.82 | 8.35 | 5.13 | 4.65 |
| Yield(%) | 0.21 | 0.35 | 0.50 | 0.72 | 0.77 |
| EV/Net Sales(x) | 6.87 | 5.06 | 5.69 | 3.17 | 3.35 |
| EV/Core EBITDA(x) | 142.37 | 76.18 | 45.44 | 179.81 | 52.93 |
| EV/EBIT(x) | -109.02 | -332.68 | 58.52 | -1,325.56 | 81.17 |
| EV/CE(x) | 11.85 | 8.81 | 5.37 | 3.96 | 3.61 |
| M Cap / Sales | 6.80 | 5.07 | 5.71 | 3.19 | 3.36 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 28.96 | 6.67 | 22.86 | 12.25 | 11.07 |
| Core EBITDA Growth(%) | -6.25 | -43.44 | 771.77 | -68.74 | -35.09 |
| EBIT Growth(%) | -434.65 | -116.68 | 5,090.41 | -106.50 | -50.19 |
| PAT Growth(%) | -148.54 | -164.81 | 4,364.05 | -107.62 | -50.59 |
| EPS Growth(%) | -141.94 | -164.81 | 4,262.36 | -107.62 | -64.71 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.16 | - | - | - | - |
| Current Ratio(x) | 1.51 | 2.08 | 2.14 | 3.36 | 3.17 |
| Quick Ratio(x) | 0.79 | 1.05 | 1.33 | 1.81 | 1.80 |
| Interest Cover(x) | -2.38 | -0.83 | 39.77 | -2.33 | 56.64 |
| Total Debt/Mcap(x) | 0.01 | - | - | - | - |
Compare Financial Ratios of peers of ZOTA HEALTH CARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZOTA HEALTH CARE | ₹2,163.0 Cr | 2.1% | 43.1% | 58.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,920.0 Cr | -0.1% | 1.7% | 45.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,160.0 Cr | -0.1% | -2.2% | 56.9% | Stock Analytics | |
| CIPLA | ₹118,917.0 Cr | 1.7% | 0.5% | 23.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,017.0 Cr | 5.7% | 12.4% | 18.5% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹97,997.1 Cr | -1.4% | 3.1% | 44.8% | Stock Analytics | |
ZOTA HEALTH CARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZOTA HEALTH CARE | 2.1% |
43.1% |
58.7% |
| SENSEX | -5% |
0.6% |
9.2% |
You may also like the below Video Courses
